retatrutide glp-1 gip glucagon receptor agonist is a triple-agonist (GLP-1 + + glucagon) and recent clinical trials are showing remarkable outcomes in obesity treatment. 🔬 Latest data highlights: • ~25–30% average body-weight reduction in long-term trials heart Items included:Daily Fiber+ | Daily Cortisol Support | GLP-1 Support GLP-1 receptor agonists: a

retatrutide glp-1 gip glucagon receptor agonist is a triple-agonist (GLP-1 + + glucagon) and recent clinical trials are showing remarkable outcomes in obesity treatment. 🔬 Latest data highlights: • ~25–30% average body-weight reduction in long-term trials heart Items included:Daily Fiber+ | Daily Cortisol Support | GLP-1 Support GLP-1 receptor agonists: a

GLP-1 receptor agonists: a review of head-to-head clinical studies - PMC

Touzalin recently ran into this barrier herself

heart

Items included:Daily Fiber+ | Daily Cortisol Support | GLP-1 Support

The participants performed a comprehensive literature search using prespecified keys (Supplementary Table S2)